1
|
Carey-Morgan H, Polley N, Korten T, Pacholski C, Diez S. Microscope-Free Analyte Detection Based on Fiber-Optic Gliding Motility Assays. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2025:e2411836. [PMID: 40237207 DOI: 10.1002/smll.202411836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2024] [Revised: 01/29/2025] [Indexed: 04/18/2025]
Abstract
Prolonged hospital waiting times are linked with increased patient mortality and cause additional financial burdens on institutions. Efficient point-of-care diagnosis would help alleviate this, but is hampered by a lack of cost-effective devices capable of rapid, in situ, wide ranging analyte detection. Lab-on-fiber technology provides an answer allowing for diagnosis, treatment, and monitoring in situ with real time feedback. Here, a device is demonstrated that harnesses motor-protein-driven-microtubule molecular detection assays to optical fibers. By developing a new method for microscope-free microtubule gliding speed determination, proof of concept is demonstrated in the detection of Monomeric Streptavidin and Neutravidin, which initiate a decrease in speed in biotinylated microtubules as well as bundling in the latter case. Utilizing antibody functionalizsed microtubules label-free and microscope-free detection of the heart attack marker Creatine Kinase-MB, as well secondary antibodies in nm concentration is demonstrated. This detector has the potential to be used in situ, providing rapid, low-cost, multiplex analyte screening and detection.
Collapse
Affiliation(s)
- Henry Carey-Morgan
- B CUBE - Center for Molecular Bioengineering, TUD University of Technology Dresden, 01307, Dresden, Germany
| | - Nabarun Polley
- Institute of Chemistry, Physical Chemistry - innoFSPEC, University of Potsdam, Am Mühlenberg 3, 14476, Potsdam, Germany
| | - Till Korten
- Helmholtz Zentrum Dresden Rossendorf HZDR, 01328, Dresden, Germany
| | - Claudia Pacholski
- Institute of Chemistry, Physical Chemistry - innoFSPEC, University of Potsdam, Am Mühlenberg 3, 14476, Potsdam, Germany
| | - Stefan Diez
- B CUBE - Center for Molecular Bioengineering, TUD University of Technology Dresden, 01307, Dresden, Germany
- Max Planck Institute for Molecular Cell Biology and Genetics, 01307, Dresden, Germany
- Cluster of Excellence Physics of Life, TUD University of Technology Dresden, 01062, Dresden, Germany
| |
Collapse
|
2
|
Zhou X, Sun M, Yang X, Shao M, Jin M, She Y, Yang Q, Yang G. F OF 1-ATPase Biomolecular Motor: Structure, Motility Manipulations, and Biomedical Applications. Biomacromolecules 2025; 26:773-786. [PMID: 39797787 DOI: 10.1021/acs.biomac.4c01553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2025]
Abstract
Biomolecular motors are dynamic systems found in organisms with high energy conversion efficiency. FOF1-ATPase is a rotary biomolecular motor known for its near 100% energy conversion efficiency. It utilizes the synthesis and hydrolysis of ATP to induce conformational changes in motor proteins, thereby converting chemical energy into mechanical motion. Given their high efficiency, autonomous propulsion capability, and modifiable structures, FOF1-ATPase motors have attracted significant attention for potential biomedical applications. This Review aims to introduce the detailed structure of FOF1-ATPase, explore various motility manipulation strategies, and summarize its applications in biological detection and cargo delivery. Additionally, innovative research methods are proposed to analyze the motion mechanism of FOF1-ATPase more comprehensively, with the goal of advancing its biomedical applications. Finally, this Review concludes with key insights and future perspectives.
Collapse
Affiliation(s)
- Xuhui Zhou
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, PR China
- Department of Pharmacy, Jinhua Municipal Central Hospital, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, Zhejiang, PR China
| | - Miao Sun
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, PR China
| | - Xiu Yang
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, PR China
| | - Mengliu Shao
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, PR China
| | - Mengya Jin
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, PR China
| | - Yuanbin She
- College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, PR China
| | - Qingliang Yang
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, PR China
| | - Gensheng Yang
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, PR China
- Eastern Institute for Advanced Study, Ningbo 315201, Zhejiang, PR China
| |
Collapse
|
3
|
Melbacke A, Salhotra A, Ušaj M, Månsson A. Improved longevity of actomyosin in vitro motility assays for sustainable lab-on-a-chip applications. Sci Rep 2024; 14:22768. [PMID: 39354041 PMCID: PMC11445438 DOI: 10.1038/s41598-024-73457-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Accepted: 09/17/2024] [Indexed: 10/03/2024] Open
Abstract
In the in vitro motility assay (IVMA), actin filaments are observed while propelled by surface-adsorbed myosin motor fragments such as heavy meromyosin (HMM). In addition to fundamental studies, the IVMA is the basis for a range of lab-on-a-chip applications, e.g. transport of cargoes in nanofabricated channels in nanoseparation/biosensing or the solution of combinatorial mathematical problems in network-based biocomputation. In these applications, prolonged myosin function is critical as is the potential to repeatedly exchange experimental solutions without functional deterioration. We here elucidate key factors of importance in these regards. Our findings support a hypothesis that early deterioration in the IVMA is primarily due to oxygen entrance into in vitro motility assay flow cells. In the presence of a typically used oxygen scavenger mixture (glucose oxidase, glucose, and catalase), this leads to pH reduction by a glucose oxidase-catalyzed reaction between glucose and oxygen but also contributes to functional deterioration by other mechanisms. Our studies further demonstrate challenges associated with evaporation and loss of actin filaments with time. However, over 8 h at 21-26 °C, there is no significant surface desorption or denaturation of HMM if solutions are exchanged manually every 30 min. We arrive at an optimized protocol with repeated exchange of carefully degassed assay solution of 45 mM ionic strength, at 30 min intervals. This is sufficient to maintain the high-quality function in an IVMA over 8 h at 21-26 °C, provided that fresh actin filaments are re-supplied in connection with each assay solution exchange. Finally, we demonstrate adaptation to a microfluidic platform and identify challenges that remain to be solved for real lab-on-a-chip applications.
Collapse
Affiliation(s)
- Andreas Melbacke
- Department of Chemistry and Biomedical Sciences, Linnaeus University, 39182, Kalmar, Sweden
| | - Aseem Salhotra
- Department of Chemistry and Biomedical Sciences, Linnaeus University, 39182, Kalmar, Sweden
| | - Marko Ušaj
- Department of Chemistry and Biomedical Sciences, Linnaeus University, 39182, Kalmar, Sweden.
| | - Alf Månsson
- Department of Chemistry and Biomedical Sciences, Linnaeus University, 39182, Kalmar, Sweden.
| |
Collapse
|
4
|
Månsson A. The potential of myosin and actin in nanobiotechnology. J Cell Sci 2023; 136:292584. [PMID: 36861886 DOI: 10.1242/jcs.261025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/03/2023] Open
Abstract
Since the late 1990s, efforts have been made to utilize cytoskeletal filaments, propelled by molecular motors, for nanobiotechnological applications, for example, in biosensing and parallel computation. This work has led to in-depth insights into the advantages and challenges of such motor-based systems, and has yielded small-scale, proof-of-principle applications but, to date, no commercially viable devices. Additionally, these studies have also elucidated fundamental motor and filament properties, as well as providing other insights obtained from biophysical assays in which molecular motors and other proteins are immobilized on artificial surfaces. In this Perspective, I discuss the progress towards practically viable applications achieved so far using the myosin II-actin motor-filament system. I also highlight several fundamental pieces of insights derived from the studies. Finally, I consider what may be required to achieve real devices in the future or at least to allow future studies with a satisfactory cost-benefit ratio.
Collapse
Affiliation(s)
- Alf Månsson
- Department of Chemistry and Biomedical Science, Linnaeus University, SE-391 82 Kalmar, Sweden
| |
Collapse
|
5
|
Meinecke CR, Heldt G, Blaudeck T, Lindberg FW, van Delft FCMJM, Rahman MA, Salhotra A, Månsson A, Linke H, Korten T, Diez S, Reuter D, Schulz SE. Nanolithographic Fabrication Technologies for Network-Based Biocomputation Devices. MATERIALS (BASEL, SWITZERLAND) 2023; 16:1046. [PMID: 36770052 PMCID: PMC9920894 DOI: 10.3390/ma16031046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Revised: 01/13/2023] [Accepted: 01/18/2023] [Indexed: 06/18/2023]
Abstract
Network-based biocomputation (NBC) relies on accurate guiding of biological agents through nanofabricated channels produced by lithographic patterning techniques. Here, we report on the large-scale, wafer-level fabrication of optimized microfluidic channel networks (NBC networks) using electron-beam lithography as the central method. To confirm the functionality of these NBC networks, we solve an instance of a classical non-deterministic-polynomial-time complete ("NP-complete") problem, the subset-sum problem. The propagation of cytoskeletal filaments, e.g., molecular motor-propelled microtubules or actin filaments, relies on a combination of physical and chemical guiding along the channels of an NBC network. Therefore, the nanofabricated channels have to fulfill specific requirements with respect to the biochemical treatment as well as the geometrical confienement, with walls surrounding the floors where functional molecular motors attach. We show how the material stack used for the NBC network can be optimized so that the motor-proteins attach themselves in functional form only to the floor of the channels. Further optimizations in the nanolithographic fabrication processes greatly improve the smoothness of the channel walls and floors, while optimizations in motor-protein expression and purification improve the activity of the motor proteins, and therefore, the motility of the filaments. Together, these optimizations provide us with the opportunity to increase the reliability of our NBC devices. In the future, we expect that these nanolithographic fabrication technologies will enable production of large-scale NBC networks intended to solve substantially larger combinatorial problems that are currently outside the capabilities of conventional software-based solvers.
Collapse
Affiliation(s)
- Christoph R. Meinecke
- Center for Microtechnologies, Chemnitz University of Technology, 09107 Chemnitz, Germany
- Department Nano Device Technologies, Fraunhofer Institute for Electronic Nano Systems (ENAS), 09126 Chemnitz, Germany
| | - Georg Heldt
- Department Nano Device Technologies, Fraunhofer Institute for Electronic Nano Systems (ENAS), 09126 Chemnitz, Germany
| | - Thomas Blaudeck
- Center for Microtechnologies, Chemnitz University of Technology, 09107 Chemnitz, Germany
- Department Nano Device Technologies, Fraunhofer Institute for Electronic Nano Systems (ENAS), 09126 Chemnitz, Germany
- Research Center for Materials, Architectures and Integration of Nanomembranes (MAIN), Chemnitz University of Technology, 09126 Chemnitz, Germany
| | - Frida W. Lindberg
- NanoLund and Solid State Physics, Lund University, 22100 Lund, Sweden
| | | | | | - Aseem Salhotra
- Department of Chemistry and Biomedical Sciences, Linnaeus University, 39182 Kalmar, Sweden
| | - Alf Månsson
- Department of Chemistry and Biomedical Sciences, Linnaeus University, 39182 Kalmar, Sweden
| | - Heiner Linke
- NanoLund and Solid State Physics, Lund University, 22100 Lund, Sweden
| | - Till Korten
- B CUBE—Center for Molecular Bioengineering and Cluster of Excellence Physics of Life, Technische Universität Dresden, 01307 Dresden, Germany
| | - Stefan Diez
- B CUBE—Center for Molecular Bioengineering and Cluster of Excellence Physics of Life, Technische Universität Dresden, 01307 Dresden, Germany
- Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany
| | - Danny Reuter
- Center for Microtechnologies, Chemnitz University of Technology, 09107 Chemnitz, Germany
- Department Nano Device Technologies, Fraunhofer Institute for Electronic Nano Systems (ENAS), 09126 Chemnitz, Germany
| | - Stefan E. Schulz
- Center for Microtechnologies, Chemnitz University of Technology, 09107 Chemnitz, Germany
- Department Nano Device Technologies, Fraunhofer Institute for Electronic Nano Systems (ENAS), 09126 Chemnitz, Germany
- Research Center for Materials, Architectures and Integration of Nanomembranes (MAIN), Chemnitz University of Technology, 09126 Chemnitz, Germany
| |
Collapse
|
6
|
Yang Q, Gao Y, Xu L, Hong W, She Y, Yang G. Enzyme-driven micro/nanomotors: Recent advances and biomedical applications. Int J Biol Macromol 2020; 167:457-469. [PMID: 33278445 DOI: 10.1016/j.ijbiomac.2020.11.215] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2020] [Revised: 11/17/2020] [Accepted: 11/30/2020] [Indexed: 10/22/2022]
Abstract
Micro/nanomotors (MNMs), both self-propelled actuators and external fields-promoted machines, have joined forces in the past decade to accomplish versatile tasks such as precise detection and targeted cargo delivery with adequate propulsion and desirable locomotion. Amongst, enzyme-driven MNMs have been able to differentiate themselves from others owing to their distinct characteristics, such as absence of chemical fuel, enhanced cellular uptake and the possibility to be easily conjugated with many therapeutics, including both small molecules and biologics, displaying superior efficacy, enhanced specificity and diminished side effects. In the present review, we aim to highlight and summarize recent advances in enzyme-driven MNMs, particularly to provide an in-depth discussion focusing on the enzyme linking approaches onto those MNMs and motion control strategies of such MNMs with advantages and limitations thereof. Conclusions and future perspectives are also provided in brief.
Collapse
Affiliation(s)
- Qingliang Yang
- Research Institute of Pharmaceutical Particle Technology, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China
| | - Ying Gao
- Research Institute of Pharmaceutical Particle Technology, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China
| | - Lei Xu
- Research Institute of Pharmaceutical Particle Technology, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China
| | - Weiyong Hong
- Research Institute of Pharmaceutical Particle Technology, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China; Taizhou Municipal Hospital of Zhejiang Province, Taizhou 318000, China
| | - Yuanbin She
- College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, China
| | - Gensheng Yang
- Research Institute of Pharmaceutical Particle Technology, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.
| |
Collapse
|